期刊文献+

乳腺癌MRI形态学表现与C-erbB-2表达的相关性研究 被引量:6

Relation of MRI morphological features and the expression of C-erbB-2 in breast cancer
下载PDF
导出
摘要 目的 探讨乳腺癌MRI形态学表现与C erbB 2癌基因的相关性。方法 对 78例乳腺癌和 42例乳腺纤维腺瘤患者术前行乳腺MR扫描 ,分析乳腺癌的MRI形态学表现。术后标本行免疫组织化学染色测定肿瘤细胞C erbB 2的表达情况 ,并分析与相应病灶MRI表现的关系。结果 乳腺癌MRI多表现为边缘形态不规则或毛刺状边缘、边界模糊、瘤内有坏死。乳腺癌内部坏死与癌细胞C erbB 2阳性表达呈显著正相关 (r=0 .2 7,P <0 .0 5 ) ;而边界模糊、毛刺状边缘与癌细胞C erbB 2表达情况无显著相关性 (r =0 .11,r=-0 .13 ,P >0 .0 5 )。结论 乳腺癌MRI形态学表现与分子生物学指标C erbB 2之间存在一定的相关性。乳腺癌的MRI表现从一定程度上反映了癌细胞的生物学行为和预后 ,为临床治疗方案的选择提供客观依据。 Objective To investigate the correlativity between magnetic resonance imaging (MRI) morphological features and the expression of C erbB 2 in breast cancer. Methods MR scanning was performed on 78 patients with breast cancer and 42 patients with fibroadenoma before operation. The MRI morphological features of breast cancer were analyzed. C erbB 2 expression of the specimens of the patients with breast cancer and fibroadenoma after mastectomy were determined by immunohistochemistry. The relationship between the immunohistochemical results and the MRI morphological features was analyzed. Results Irregular shape or spiculated margin, obscure margin and necrotic center were found more frequently on plain MRI in patients with breast cancer. C erbB 2 positive expression was positively correlated with necrotic center of breast cancer ( P <0.05) but the expression of C erbB 2 was not significantly correlated with spiculated margin and obscure margin of breast cancer ( P >0.05). Conclusion There is correlation between MRI morphological features and the expression of C erbB 2 of breast cancer to a certain degree. MRI features can reflect the biologic behavior and prognosis of breast cancer, which can provide evidence for clinical treatment planning of breast cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2003年第12期1109-1112,共4页 Journal of Third Military Medical University
关键词 乳腺癌 磁共振成像 C-ERBB-2癌基因 breast cancer magnetic resonance imaging C erbB 2 oncogene
  • 相关文献

参考文献10

  • 1[1]Nunes L W, Schnall M D, Siegelman E S, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast[J]. AJR, 1997, 169(2): 409-415.
  • 2[2]Ikeda O, Yamashita Y, Morishita S, et al. Characterization of breast masses by dynamic enhanced MR imaging. A logistic regression analysis[J]. Acta Radiol, 1999, 40(6): 585-592.
  • 3[3]Pham C D, Roberts T P, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor[J]. Cancer Invest, 1998, 16(4): 225-230.
  • 4[4]Bone B, Aspelin P, Bronge L, et al. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer[J]. Acta Radiol, 1998, 39(3): 279-284.
  • 5[5]Fitzgibbons P L, Page D L, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999[J]. Arch Pathol Lab Med, 2000, 124(7): 966-978.
  • 6[6]Cooke T, Reeves J, Lannigan A, et al. The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker[J]. Eur J Cancer, 2001,37(1):3-10.
  • 7[7]Tan M, Yao J, Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential human breast cancer cell without increasing their transformation abilities[J]. Cancer Res, 1997, 57(6): 1199-1205.
  • 8[8]Tetu B, Brisson J. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer[J]. Cancer, 1994, 73(9): 2359-2365.
  • 9[9]Paik S, Bryant J, Park C, et al. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer[J]. J Natl Cancer Inst, 1998, 90(18): 1361-1370.
  • 10[10]Evans A J, Pinder S E, Ellis I O, et al. Correlations between the mammographic features of ductal carcinoma in situ(DCIS) and c-erbB-2 oncogene expression[J]. Clin Radiol, 1994, 49(8): 559-562.

同被引文献41

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部